FOXP3 and type 1 diabetes mellitus: In addition, the lower expression level of FOXP3 in CCR5 + Tregs in T1D may contribute to their inability to sufficiently suppress the expansion of pathogenic effector T cells, which may contribute to shifting the balance toward inflammatory Th17 cells as it was previously described by us [25].